243 related articles for article (PubMed ID: 16442114)
1. Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
Ouyang P; Tardif JC; Herrington DM; Stewart KJ; Thompson PD; Walsh MN; Bennett SK; Heldman AW; Tayback MA; Wang NY;
Atherosclerosis; 2006 Dec; 189(2):375-86. PubMed ID: 16442114
[TBL] [Abstract][Full Text] [Related]
2. Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial.
Kotsia AP; Rangan BV; Christopoulos G; Coleman A; Roesle M; Cipher D; de Lemos JA; McGuire DK; Packer M; Banerjee S; Brilakis ES
J Invasive Cardiol; 2015 Oct; 27(10):E204-10. PubMed ID: 26429851
[TBL] [Abstract][Full Text] [Related]
3. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.
Rodés-Cabau J; Facta A; Larose E; DeLarochellière R; Déry JP; Nguyen CM; Roy L; Proulx G; Gleeton O; Barbeau G; Noël B; Rouleau J; Boudreault JR; Bertrand OF
Am J Cardiol; 2007 Aug; 100(4):640-5. PubMed ID: 17697821
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
Taggart DP; Ben Gal Y; Lees B; Patel N; Webb C; Rehman SM; Desouza A; Yadav R; De Robertis F; Dalby M; Banning A; Channon KM; Di Mario C; Orion E
Ann Thorac Surg; 2015 Jun; 99(6):2039-45. PubMed ID: 25886810
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
[TBL] [Abstract][Full Text] [Related]
6. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
Olenchock SA; Karmpaliotis D; Gibson WJ; Murphy SA; Southard MC; Ciaglo L; Buros J; Mack MJ; Alexander JH; Harrington RA; Califf RM; Kouchoukos NT; Ferguson TB; Gibson CM
Ann Thorac Surg; 2008 Feb; 85(2):520-4. PubMed ID: 18222256
[TBL] [Abstract][Full Text] [Related]
7. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
Une D; Kulik A; Voisine P; Le May M; Ruel M
Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
[TBL] [Abstract][Full Text] [Related]
8. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
Rodés-Cabau J; Bertrand OF; Larose E; Déry JP; Rinfret S; Bagur R; Proulx G; Nguyen CM; Côté M; Landcop MC; Boudreault JR; Rouleau J; Roy L; Gleeton O; Barbeau G; Noël B; Courtis J; Dagenais GR; Després JP; DeLarochellière R
Circulation; 2009 Nov; 120(20):1978-86. PubMed ID: 19884468
[TBL] [Abstract][Full Text] [Related]
9. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study.
Johansson BL; Souza DS; Bodin L; Filbey D; Loesch A; Geijer H; Bojö L
Eur J Cardiothorac Surg; 2010 Oct; 38(4):414-9. PubMed ID: 20362457
[TBL] [Abstract][Full Text] [Related]
10. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
[TBL] [Abstract][Full Text] [Related]
12. Angiographic predictors of 6-month patency of bypass grafts implanted to the right coronary artery a prospective randomized comparison of gastroepiploic artery and saphenous vein grafts.
Glineur D; D'hoore W; El Khoury G; Sondji S; Kalscheuer G; Funken JC; Rubay J; Poncelet A; Astarci P; Verhelst R; Noirhomme P; Hanet C
J Am Coll Cardiol; 2008 Jan; 51(2):120-5. PubMed ID: 18191734
[TBL] [Abstract][Full Text] [Related]
13. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.
Halabi AR; Alexander JH; Shaw LK; Lorenz TJ; Liao L; Kong DF; Milano CA; Harrington RA; Smith PK
Am J Cardiol; 2005 Nov; 96(9):1254-9. PubMed ID: 16253593
[TBL] [Abstract][Full Text] [Related]
14. Peri-stent reference segment plaque burden is associated with disease progression in saphenous vein grafts (a serial intravascular ultrasound assessment).
Hong YJ; Mintz GS; Kim SW; Okabe T; Lu L; Bui AB; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
Am J Cardiol; 2007 Oct; 100(8):1233-8. PubMed ID: 17920363
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of saphenous vein bypass vs. native coronary artery balloon angioplasty: technical differences and angiographic response.
Kimball BP; Bui S
Cathet Cardiovasc Diagn; 1995 Apr; 34(4):293-9; discussion 300. PubMed ID: 7621538
[TBL] [Abstract][Full Text] [Related]
16. Effect of coronary artery bypass grafting on native coronary artery stenosis. Comparison of internal thoracic artery and saphenous vein grafts.
Hamada Y; Kawachi K; Yamamoto T; Nakata T; Kashu Y; Watanabe Y; Sato M
J Cardiovasc Surg (Torino); 2001 Apr; 42(2):159-64. PubMed ID: 11292927
[TBL] [Abstract][Full Text] [Related]
17. Disease progression in nonintervened saphenous vein graft segments a serial intravascular ultrasound analysis.
Hong YJ; Mintz GS; Kim SW; Lee SY; Kim SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
J Am Coll Cardiol; 2009 Apr; 53(15):1257-64. PubMed ID: 19358938
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ruptured plaques in native coronary arteries and in saphenous vein grafts: an intravascular ultrasound study.
Pregowski J; Tyczynski P; Mintz GS; Kim SW; Witkowski A; Waksman R; Pichard A; Satler L; Kent K; Kalinczuk L; Bieganski S; Ohlmann P; Maehara A; Weissman NJ
Am J Cardiol; 2006 Mar; 97(5):593-7. PubMed ID: 16490419
[TBL] [Abstract][Full Text] [Related]
20. Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial.
Kulik A; Abreu AM; Boronat V; Ruel M
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):151-161.e1. PubMed ID: 30122341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
